Fundraising FoxALS Investment Fund
Venture capitalAmsterdam · Seed · 9 people tracked
Find your way into ALS Investment Fund
Sign up to see every warm intro you have to ALS Investment Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ALS Investment Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
ALS Investment Fund backs biotech companies developing therapies for neurodegeneration, with a special emphasis on ALS. The firm highlights that neurodegeneration is a leading cause of death and disability, affecting roughly one in five people, with ALS affecting about one in 350. It believes new drugs could meaningfully improve quality of life within the next decade by preserving cognition and motor function, potentially turning neurodegenerative diseases into managed conditions. Having operated for about ten years, the fund supports people and companies working to change the trajectory of these diseases and accelerate a new generation of treatments.
Source: firm website, verified Oct 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 10 of 11 portfolio companiesBiotech ×10Deep Tech ×5Healthtech ×5Medical Devices ×4Digital Health ×2AI & Machine Learning ×1
HQs:United States×8Netherlands×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2023 · 12021 · 34 dated
Amylyx is a biopharmaceutical company developing novel therapies for diseases with high unmet medical needs.
BiotechHealthtechCambridge, US
Justin Klee(Director)inJoshua Cohen(Founder)in
BoardStephen D. Chubb(Director)George M. Milne, PH.D.(Director)
Co-investorsAlpha Wave GlobalAvoro Capital AdvisorsBain Capital Life Sciences
BiotechCoralville, US
Travis C. Mickle(Executive Officer, Director, Promoter)Christal M.M. Mickle(Executive Officer, Director)Gordon K. Johnson(Executive Officer)Tracy M. Woody(Executive Officer)Sven Guenther(Executive Officer, Director)Neil F. McFarlane(President, Chief Executive Officer and Director)
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsJoyance PartnersPsyMed VenturesSocial StartsApollo Health VenturesLeaps by Bayer
Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.
BiotechDeep TechHealthtech
Donald Ingber(Founder)inDaniel Levner(Co-Founder & CTO)inJim Corbett(CEO, Board Member)inLorna Ewart(Chief Scientific Officer)in
Co-investors+ND CapitalNorthpond VenturesAlumni VenturesAlwyn CapitalFourth RealmStray Dog Capital+4 more
Prilenia is a biotechnology company developing treatments for neurodegenerative diseases, including Huntington's disease and amyotrophic lateral sclerosis (ALS).
BiotechHealthtechMedical Devices
Co-investorsSV Health InvestorsAmplitude Venture CapitalForbion
ProJenX is a clinical-stage biotechnology company developing novel, brain-penetrant therapies for neurodegenerative diseases, with an initial focus on amyotrophic lateral sclerosis (ALS).
BiotechDeep TechMedical DevicesNissequogue, US
Valerie Estess(Director)
BoardJohn Prufeta(Director)inEric Heil(Director)inJoni Mancini(Executive Officer)inBrent R. Stockwell(Chair of the Department of Biological Science, Professor at Columbia University)Hynek Wichterle(Jerry and Emily Spiegel Professor at Columbia University)
Co-investorsMedical Excellence Capital
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission BiocapitalMitsui Global Investment+8 more
uniQure is a biotech company developing gene therapies for serious genetic diseases.
BiotechHealthtechMedical Devices
Co-investorsAdvent Life SciencesForesite CapitalHEALTHCARE ROYALTY PARTNERSRidgeback CapitalForbion
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(CEO)inJason Chen(Founder)inEmily Ripka(Vice President Product \u0026 Engineering)inNaveen Jain(Investor)inGeorge Spencer(Operations)
Co-investorsAgent CapitalBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin Ventures+28 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Apic BioVectory
Exits · 2
2 IPOsPortfolio news
latest coverage across their companiesAmylyx · biopharminternational.com · Aug 20, 2026
Frequently asked questions
- How many investments has ALS Investment Fund made?
- ALS Investment Fund has 11 tracked investments, 2 of which have exited.
- What stage does ALS Investment Fund invest at?
- ALS Investment Fund invests at the Seed stage.
- What sectors does ALS Investment Fund focus on?
- ALS Investment Fund focuses on Biotech, Healthtech.
- Where is ALS Investment Fund located?
- ALS Investment Fund is headquartered in Amsterdam, NL.
- Who does ALS Investment Fund co-invest with?
- ALS Investment Fund most often shares deals with SV Health Investors, Draper Associates, Medical Excellence Capital, among 38 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.